
Shanghai Pharmaceuticals Holding Co., Ltd
2607.HKHKSEHealthcareMedical - Distribution
Latest quote
HK$11.52
−HK$0.15 · -1.29%
2607.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteShanghai Pharmaceuticals Holding Co., Ltd., an investment holding company based in Shanghai, People's Republic of China, maintains a robust presence across the pharmaceutical and healthcare industries. Its core activities involve the research, development, production, distribution, and retail of medical and wellness products. The company is strategically divided into Production, Distribution, Retail, and Other segments. Its comprehensive product portfolio includes Western and traditional Chinese medicines, health supplements, and medical devices, addressing a broad spectrum of therapeutic areas such as oncology, cardiovascular health, central nervous system disorders, general infections, immunology, digestive and metabolic conditions, and respiratory ailments, totaling approximately 700 distinct drug varieties. Beyond manufacturing, Shanghai Pharmaceuticals offers extensive pharmaceutical supply chain solutions, encompassing warehousing, logistics, and value-added services for manufacturers, hospitals, distributors, and retail pharmacies. The company also boasts a significant retail footprint, operating a network of approximately 2,000 retail pharmacies across 24 provinces, alongside an active online drug business. Furthermore, it provides various specialized services, including consulting, asset management, clinical trials, medical aid programs, physician and patient education, e-prescription management, and remote/cloud-based hospital services. Established in 1994, Shanghai Pharmaceuticals Holding Co., Ltd. operates as a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Qiuhua Yang
- Listed since
- May 20, 2011
- Employees
- 49,608
Market position
Day range
Current HK$11.52
52-week range
Current HK$11.52
- Open
- HK$11.71
- Previous close
- HK$11.67
- Volume
- 1.38M
- 0.52× average
- Average volume
- 2.66M
- Average daily volume
- Market cap
- 66.82B HKD
- Beta
- 0.22
- Market reference 1
- 50-day average
- HK$11.8486
- -2.77% below average
- 200-day average
- HK$11.7929
- -2.31% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 54.66B CNY
- P/E (TTM)
- 10.31×
- P/B (TTM)
- 0.78×
- P/S (TTM)
- 0.21×
- EV / EBITDA
- 3.8×
- Earnings yield
- 15.10%
- Free cash flow yield
- 10.10%
- Dividend yield
- 2.90%
Profitability & efficiency
- Gross margin
- 10.83%
- Operating margin
- 3.53%
- Net margin
- 2.02%
- Return on equity
- 7.54%
- Return on assets
- 2.46%
- Return on invested capital
- 4.97%
Financial health
- Debt / equity
- 0.81×
- Current ratio
- 1.33×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 283.58B CNY | 275.25B CNY | 260.3B CNY | 231.98B CNY | 215.82B CNY |
| Cost of goods sold | 253.16B CNY | 244.62B CNY | 229.37B CNY | 201.49B CNY | 187.28B CNY |
| Gross profit | 30.42B CNY | 30.63B CNY | 30.93B CNY | 30.49B CNY | 28.54B CNY |
| Research and development | 2.34B CNY | 2.39B CNY | 2.2B CNY | 2.11B CNY | 1.99B CNY |
| Selling, general, and administrative | 18.52B CNY | 9.53B CNY | 10.9B CNY | 15.48B CNY | 14.73B CNY |
| Operating expenses | 20.47B CNY | 22.49B CNY | 23.26B CNY | 21.71B CNY | 20.62B CNY |
| Interest income | 404.97M CNY | 522.39M CNY | 387.82M CNY | 438.3M CNY | 338.18M CNY |
| Interest expense | 1.69B CNY | 1.63B CNY | 1.66B CNY | 1.69B CNY | 1.52B CNY |
| Depreciation and amortization | 2.86B CNY | 2.42B CNY | 2.19B CNY | 2.22B CNY | 2.14B CNY |
| Operating income | 9.94B CNY | 8.14B CNY | 7.67B CNY | 9.01B CNY | 8.21B CNY |
| Net income | 5.72B CNY | 4.55B CNY | 3.77B CNY | 5.62B CNY | 5.09B CNY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 36%
- 4 beats, 7 misses, 0 met estimates
- Average EPS surprise
- -19.99%
- 11 comparable reports
- Latest EPS result
- 0.43
- Estimate 0.4 · Beat by 7.63%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.4491
2025 complete year-22.1% since 2021
2026 partial: HK$0.4048
HK$0.5762
2,021
HK$0.4921
2,022
HK$0.6638
2,023
HK$0.528
2,024
HK$0.4491
2,025
HK$0.4048
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jul 15, 2026 | HK$0.4048Semi-Annual | Jul 16, 2026 | Aug 24, 2026 |
Dividend | Dec 29, 2025 | HK$0.1322Semi-Annual | Dec 31, 2025 | Feb 6, 2026 |
Dividend | Jul 16, 2025 | HK$0.317Annual | Jul 17, 2025 | Aug 25, 2025 |
Dividend | Sep 17, 2024 | HK$0.0874Semi-Annual | Sep 19, 2024 | Oct 25, 2024 |
Dividend | Jul 18, 2024 | HK$0.4407Semi-Annual | Jul 19, 2024 | Aug 27, 2024 |
Dividend | Jul 18, 2023 | HK$0.6638Annual | Jul 19, 2023 | Aug 28, 2023 |
Ex-dividend Jul 15, 2026
HK$0.4048
Semi-Annual
Record Jul 16, 2026 · Payment Aug 24, 2026
Ex-dividend Dec 29, 2025
HK$0.1322
Semi-Annual
Record Dec 31, 2025 · Payment Feb 6, 2026
Ex-dividend Jul 16, 2025
HK$0.317
Annual
Record Jul 17, 2025 · Payment Aug 25, 2025
Ex-dividend Sep 17, 2024
HK$0.0874
Semi-Annual
Record Sep 19, 2024 · Payment Oct 25, 2024
Ex-dividend Jul 18, 2024
HK$0.4407
Semi-Annual
Record Jul 19, 2024 · Payment Aug 27, 2024
Ex-dividend Jul 18, 2023
HK$0.6638
Annual
Record Jul 19, 2023 · Payment Aug 28, 2023
2607.HK peers
ETFs holding 2607.HK
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS15.37M0.00%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO13.42M0.01%162.3B USD0.06%$60.45+0.72%
First Trust Emerging Markets AlphaDEX FundFEM3.21M0.40%805.1M USD0.80%$32.88+1.01%
Invesco S&P Emerging Markets Low Volatility ETFEELV2.37M0.57%429.35M USD0.29%$28.82+0.59%
Vanguard FTSE All-World ex-US ETFVEU2.16M0.00%95.9B USD0.04%$85.69+0.82%
Schwab Emerging Markets Equity ETFSCHE1.29M0.01%12.89B USD0.06%$36.97+0.71%
Vanguard Total World Stock ETFVT1.21M0.00%97.9B USD0.06%$160.77+0.53%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM1.14M0.01%9.49B USD0.39%$39.93+0.50%
Vanguard Total International Stock ETFVXUS- Market value
- 15.37M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO- Market value
- 13.42M
- Weight
- 0.01%
- AUM
- 162.3B USD
- Expense ratio
- 0.06%
- Price / 1D
- $60.45+0.72%
First Trust Emerging Markets AlphaDEX FundFEM- Market value
- 3.21M
- Weight
- 0.40%
- AUM
- 805.1M USD
- Expense ratio
- 0.80%
- Price / 1D
- $32.88+1.01%
Invesco S&P Emerging Markets Low Volatility ETFEELV- Market value
- 2.37M
- Weight
- 0.57%
- AUM
- 429.35M USD
- Expense ratio
- 0.29%
- Price / 1D
- $28.82+0.59%
Vanguard FTSE All-World ex-US ETFVEU- Market value
- 2.16M
- Weight
- 0.00%
- AUM
- 95.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $85.69+0.82%
Schwab Emerging Markets Equity ETFSCHE- Market value
- 1.29M
- Weight
- 0.01%
- AUM
- 12.89B USD
- Expense ratio
- 0.06%
- Price / 1D
- $36.97+0.71%
Vanguard Total World Stock ETFVT- Market value
- 1.21M
- Weight
- 0.00%
- AUM
- 97.9B USD
- Expense ratio
- 0.06%
- Price / 1D
- $160.77+0.53%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM- Market value
- 1.14M
- Weight
- 0.01%
- AUM
- 9.49B USD
- Expense ratio
- 0.39%
- Price / 1D
- $39.93+0.50%
Continue in GoAI
Research 2607.HKresearch.disclaimer





